Enfermedades raras-ANALES DEL SISTEMA SANITARIO DE NAVARRA

http://www.cfnavarra.es/salud/anales/textos/suple31_2.htm

ANALES DEL SISTEMA SANITARIO DE NAVARRA
Enfermedades raras
Vol. 31, suplemento 2, 2008

The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathies

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T3R-4SX3NP0-D&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=44757feb1cd3228a6ef48eea38534a90

doi:10.1016/j.addr.2008.05.001


Copyright © 2008 Published by Elsevier B.V.
The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathies

References and further reading may be available for this article. To view references and further reading you must purchase this article.


M.A. Tarnopolsky, a,
aDepartment of Pediatrics and Medicine, McMaster University, 1200 Main St. W., HSC-2H26, Hamilton, Ontario, Canada L8N 3Z5

Received 23 April 2008; accepted 2 May 2008. Available online 4 July 2008.

Alpha lipoic acid and frataxin: A new indication for an old antioxidant?

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WFG-4W2W5M9-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=446442ddfc68762ae8d5723da8aee971 doi:10.1016/j.expneurol.2009.04.001
Copyright © 2009 Published by Elsevier Inc.

Discussion

Alpha lipoic acid and frataxin: A new indication for an old antioxidant?

References and further reading may be available for this article. To view references and further reading you must purchase this article.
James W. Russell, a, aDepartment of Neurology, University of Maryland School of Medicine & Maryland VA Medical Center, 22 South Greene Street, Box 175, Baltimore, MD 21201-1595, USA
Received 6 March 2009; revised 7 April 2009; accepted 7 April 2009. Available online 15 April 2009.

Low-dose idebenone treatment in Friedreich's ataxia with and without cardiac hypertrophy.

http://www.ncbi.nlm.nih.gov/pubmed/19363628?dopt=AbstractPlus&holding=f1000,f1000m,isrctn

J Neurol. 2009 Apr 12. [Epub ahead of print]

Low-dose idebenone treatment in Friedreich's ataxia with and without cardiac hypertrophy.

Rinaldi C, Tucci T, Maione S, Giunta A, De Michele G, Filla A.
Department of Neurological Sciences, University of "Federico II", Via Pansini, 5, 80131, Naples, Italy, rinaldi.ca@gmail.com.

Creating Ideal Neural Cells For Clinical Use

http://www.sciencedaily.com/releases/2009/04/090413141303.htm

Creating Ideal Neural Cells For Clinical Use
ScienceDaily (Apr. 13, 2009) — Investigators at the Burnham Institute for Medical Research (Burnham) have developed a protocol to rapidly differentiate human embryonic stem cells (hESCs) into neural progenitor cells that may be ideal for transplantation.

Human ES Cells Progress Slowly In Myelin's Direction

http://www.sciencedaily.com/releases/2009/04/090409103342.htm
Human ES Cells Progress Slowly In Myelin's Direction
ScienceDaily (Apr. 9, 2009) — Scientists from the University of Wisconsin report in the journal Development the successful generation from human embryonic stem cells of a type of cell that can make myelin, a finding that opens up new possibilities for both basic and clinical research.

Risk of Stroke and Thrombus Formation From Delay Incontinence of a PLAATO-Device in Friedreich Ataxia

1: Clin Cardiol. 2009 Apr 7. [Epub ahead of print]Risk of Stroke and Thrombus Formation From Delay Incontinence of a PLAATO-Device in Friedreich Ataxia.Stöllberger C, Finsterer J, Avanzini M, Mölzer G, Weidinger F.Second Medical Department, Krankenanstalt Rudofstiftung.We present the case of a 76-year-old female with suspected Friedreich ataxia, in whom leakage and thrombosis of a percutaneously implanted left atrial appendage occluder (PLAATO) was observed 2 years after implantation. Because of late developing leakages and thrombi, regular transesophageal echocardiographic examinations should be carried out in patients with occluded left atrial appendagaes. In view of these complications and the potential important hemodynamic role of the left atrial appendage, the benefit of its occlusion is questionable, and the indications of PLAATO should be strongly reconsidered. Copyright (c) 2009 Wiley Periodicals, Inc.PMID: 19353681 [PubMed - as supplied by publisher] Source: http://www.ncbi.nlm.nih.gov/pubmed/19353681

Team Regrows Neurons Controlling Movement in Rats

http://news.yahoo.com/s/hsn/20090406/hl_hsn/teamregrowsneuronscontrollingmovementinrats;_ylt=AsWK6hIycwjUHGBmTJZ0CTy3j7AB

Team Regrows Neurons Controlling Movement in Rats
By Jennifer ThomasHealthDay Reporter by Jennifer Thomashealthday Reporter – Mon Apr 6, 7:04 pm ET
MONDAY, April 6 (HealthDay News) --

Diagnosis and treatment of Friedreich ataxia: a European perspective.

http://www.ncbi.nlm.nih.gov/pubmed/19347027?dopt=Abstract

Nat Rev Neurol. 2009 Apr;5(4):222-34.
Related Articles

Diagnosis and treatment of Friedreich ataxia: a European perspective.

Schulz JB, Boesch S, Bürk K, Dürr A, Giunti P, Mariotti C, Pousset F, Schöls L, Vankan P, Pandolfo M.

Department of Neurology, University Hospital, RWTH Aachen, Aachen, Germany.

VIRxSYS Publishes New Study On RNA Therapy

http://www.medicalnewstoday.com/articles/145267.php

Article Date: 07 Apr 2009 - 0:00 PDT

VIRxSYS Publishes New Study On RNA Therapy